Cyp3a4, 2b6, 2c, Ugt Substrates has 1 known drug interaction based on U.S. FDA drug labeling data. Notable interactions include combinations with Phenobarbital Sodium. Patients taking Cyp3a4, 2b6, 2c, Ugt Substrates should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Moderate
- 1
Moderate (1)
- Cyp3a4, 2b6, 2c, Ugt Substrates + Phenobarbital Sodium— Phenobarbital induces these enzymes, decreasing substrate exposure and potentially reducing efficacy. Monitor and consid…